금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Saudi Arabia Set to Slash Oil Prices as Hormuz Reopens
Saudi Arabia is expected to slash the official selling prices of its crude loading for Asia in Augus...
U.S. stock market sees first outflow since March. And that may set the stage for a risk-off summer.
A trend reversal in fund-flow data may show that investors are switching their focus from tech stock...
Stock Market Today: Nasdaq Futures Slide Amid Global Tech Sell-Off; Micron, Nvidia, Sandisk Fall (Live Coverage)
Stock Market Today: The Dow Jones index fell, while Nasdaq futures dived amid a global tech sell-off...
Does EPAM (EPAM) Leaving the S&P 500 Recast Its Governance and Competitive Positioning?
In late May 2026, EPAM Systems was removed from multiple S&P 500-related indices and added to the S&P 600 Information Technology index after its shareholders approved an amendment allowing stockholder ...
Prediction: Nvidia's Stock Will Skyrocket in June
Nvidia's valuation is low compared to its peers'.
Economic convergence remains intact despite globalization slowdown, Goldman says
The Stock Market Will Drop Sharply If History Repeats. Warren Buffett Explains Why.
The 30-year Treasury yield topped 5% for 11 consecutive trading days in May; the stock market dropped sharply the last time that happened.
Nasdaq, S&P 500 Futures Edge Lower Despite AI Momentum As Iran Risks Linger: Why HPE, MRVL, INTC, TSLA, SPCE, ASTS Are In Focus
Data from Stocktwits shows that retail sentiment has held at ‘bullish’ on SPY, but sits at a cautious ‘neutral’ on QQQ.
Japan’s newly crowned top company gets a downgrade on AI ‘mania’ concerns
Deutsche Bank analyst downgraded SoftBank to hold.
That Didn't Take Long: President Donald Trump Just Threw New Fed Chair Kevin Warsh Under the Bus
The new head of the Fed has a virtually impossible task of appeasing the president and Wall Street concerning interest rates.
Abivax plunges 32% as ulcerative colitis drug efficacy overshadowed by cancer concerns
Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks
Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.
HPE outlines fiscal 2027 framework with at least $4.5B free cash flow
Oil pulls back from biggest losses as Trump says Israel, Hezbollah to stop attacks
Duke Energy seeking tech partnerships to offset nuclear expansion risks, CEO says